All Type of News
Concerns rise among Korean drug makers
The domestic pharmaceutical sector is expected to face an inevitable blow under the government’s scheme to cut drug prices as part of its efforts to stamp out illegal rebate provisions.
Prospects have been grim for...
Dong-A to conduct phase 3 study for Zydena in US
Dong-A Pharmaceutical Co., says it will carry out its Phase 3 multicenter study in the United States, designed to investigate the efficacy and safety of Zydena (udenafil) in 1,120 patients with erectile dysfunction af...
Pharmaceutical salespersons urged to get vaccine
Amid the rampant spread of the H1N1 flu virus here, the Korea Pharmaceutical Manufacturers Association (KPMA) has recently recommended that vaccinations be offered to pharmaceutical salespersons in addition to higher-...
Hospitals urged to recruit more pharmacists
Recently, the Korean Society of Health System Pharmacists has called for the government to comply with the deficiency of hospital pharmacists through utilization of pharmacy school graduates participating in BK21 proj...
Leading wholesaler calls for more fair trade environment
Zuellig Pharma Korea (ZPK) needs to sharpen their logistics business through competition rather than sub-wholesaling business activities, said Kim Ki-woon, chairman of Paikje Pharm, the largest wholesaler in Korea.
...
Leading Korean drugmakers in race for larger market share
Major leading pharmaceutical manufacturers are vying for a bigger share in the local drug market, expanding their presence.
Green Cross Corporation is expected to see its sales further rise in the fourth quarter wh...
Pharmacists to get flu vaccination
Pharmacists in charge of dispensing antiviral drugs against the H1N1 flu virus are expected to get flu shots, the Korean Pharmaceutical Association said on November 2.
The association also said the vaccination guid...
Health insurance coverage expanded to Abbott’s Synagis
Health insurance for Synagis (palivizumab) has been further expanded to those infants under less than 12 months after birth, suffering from congenital heart disease due to respiratory syncytial virus (RVS), according ...
Reckitt Benckiser Korea releases Gaviscon
Reckitt Benckiser Korea, a Korean unit of UK based Reckitt Benckiser plc, says it has recently launched Gasviscon, a non-prescription medication for the treatment of heartburn and GERED/(also known as GORD) (acid refl...
ZPK criticized for intentional delivery delay of pharmaceutical products
Zuellig Pharma Korea has been under fire for having delayed the delivery of drugs ordered by affiliated firms of Dongwon Pharma Group without specific reasons.
Dongwon officials said they placed an order with medic...
